Atlas Trials

A Double-Blind, Comparative, Randomized Clinical Study of the Pharmacokinetics, Safety, and Immunogenicity of a Single Intravenous Infusion of BCD-178 or Perjeta® in Healthy Volunteers

Clinical trial NCT05738993 · UNKNOWN

Trial details

NCT number
NCT05738993
Sponsor
Biocad
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Breast Cancer
Start date
2022-08-08
Primary completion
2023-04-30
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.